-
Information-Publications
-
Biomass-derived sulfur, nitrogen co-doped carbon dots for colorimetric and fluorescent dual mode detection of silver (I) and cell imagingDetails
-
Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate CancerDetails
-
Exploration on the Effect of Anserine on the Alleviation of Dvt and its Molecular MechanismDetails
-
Long-read sequencing of 945 Han individuals identifies novel structural variants associated with phenotypic diversity and disease susceptibilityDetails
-
ZDHHC2-Mediated AGK Palmitoylation Activates AKT–mTOR Signaling to Reduce Sunitinib Sensitivity in Renal Cell CarcinomaDetails
-
(-)-Epigallocatechin-3-gallate promotes intestinal epithelial proliferation and barrier function after ischemia/reperfusion injury via activation of Nurr1Details
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands